Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from INTEGRATED Session: Neuroendocrine Highlights

  • You have access
    Quantitative analysis with 123I-MIBG SPECT/CT for pheochromocytoma and paraganglioma
    Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Koya Nakatani and Kaori Togashi
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 147;
  • You have access
    A theranostic approach for adrenocortical neoplasia based on high adrenal CXCR4 expression.
    Christina Bluemel, Constantin Lapa, Andreas Schirbel, Martin Fassnacht, Bruno Allolio, Margret Schottelius, S. Kropf, Hans Wester, Stefanie Hahner and Ken Herrmann
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 145;
  • You have access
    68Ga-exendin-4 PET/CT is highly effective in localizing insulinomas
    Yaping Luo, Fang Li and Zhaohui Zhu
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 146;
  • You have access
    Localisation of Insulinoma: Comparison of Glucagon-like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI. Preliminary results of a prospective clinical study.
    Kwadwo Antwi, Melpomeni Fani, Tobias Heye, Guillaume Nicolas, Elmar Merkle, Jean Claude Reubi, Beat Gloor, Emanuel Christ and Damian Wild
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 144;
  • You have access
    Intrapatient 68Ga-DOTATOC/68Ga-DOTATATE uptake comparison in primary neuroendocrine tumors, metastases and normal liver.
    Mila Todorović-Tirnanić, Milan Gajić and Richard Baum
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 148;
  • You have access
    Role of Gallium-68 DOTATOC PET-CT in Neuroendocrine Tumors with Unknown Primary Site
    Yusuf Menda, Thomas O'Dorisio, Michael Graham, James Howe, David Dick, Joseph Dillon, Michael Schultz, Gordon Watkins, John Sunderland and M Sue O'Dorisio
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 143;
SNMMI

© 2025 SNMMI

Powered by HighWire